Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ciprian Tomuleasa

Showing results (161-170 of 194) with videos related to

Pageof 20
Sort By:
Frontiers in Bioengineering and Biotechnology|August 9, 2021
SERS-Based Evaluation of the DNA Methylation Pattern Associated With Progression in Clonal Leukemogenesis of Down SyndromeVlad Moisoiu, Valentina Sas, Andrei Stefancu, et al.
Frontiers in Oncology|September 26, 2019
LEAM vs. BEAM vs. CLV Conditioning Regimen for Autologous Stem Cell Transplantation in Malignant Lymphomas. Retrospective Comparison of Toxicity and Efficacy on 222 Patients in the First 100 Days After Transplant, On Behalf of the Romanian Society for Bone Marrow TransplantationAndrei Colita, Anca Colita, Horia Bumbea, et al.
Cell Death Discovery|August 13, 2025
Comprehensive view on chemotherapy-free management of acute myeloid leukemia by using venetoclax in combination with targeted and/or immune therapiesDavid Kegyes, Andrei Tat, Alin Stefan Vizitiu, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|December 24, 2015
Exosome-Carried microRNA-375 Inhibits Cell Progression and Dissemination via Bcl-2 Blocking in Colon CancerFlorin Zaharie, Mihai Stefan Muresan, Bobe Petrushev, et al.
Biomarker Research|August 15, 2025
Targeting degradation of IKZF1 and IKZF3 through modulation of the E3 ligase substrates in the context of cellular therapies for multiple myelomaDavid Kegyes, Anamaria Bancos, Adrian Bogdan Tigu, et al.
Journal of Clinical Medicine|October 29, 2020
B Cells versus T Cells in the Tumor Microenvironment of Malignant Lymphomas. Are the Lymphocytes Playing the Roles of Muhammad Ali versus George Foreman in Zaire 1974?Minodora Desmirean, Sebastian Rauch, Ancuta Jurj, et al.
Leukemia & Lymphoma|February 11, 2022
Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy<sup></sup>Toshihiro Miyamoto, David Sanford, Ciprian Tomuleasa, et al.
Critical Reviews in Clinical Laboratory Sciences|May 27, 2018
Minimal residual disease in chronic lymphocytic leukemia: A consensus paper that presents the clinical impact of the presently available laboratory approachesCiprian Tomuleasa, Cristina Selicean, Sonia Cismas, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|August 7, 2021
SERS-based DNA methylation profiling allows the differential diagnosis of malignant lymphadenopathyAndrei Stefancu, Vlad Moisoiu, Minodora Desmirean, et al.
Frontiers in Immunology|August 27, 2025
Challenges in the preclinical design and assessment of CAR-T cellsRadu Tomai, Javier De Las Rivas, Bogdan Fetica, et al.
Pageof 20

Showing results (161-170 of 194) with videos related to

Sort By:
Pageof 20
Frontiers in Bioengineering and Biotechnology|August 9, 2021
SERS-Based Evaluation of the DNA Methylation Pattern Associated With Progression in Clonal Leukemogenesis of Down SyndromeVlad Moisoiu, Valentina Sas, Andrei Stefancu, et al.
Frontiers in Oncology|September 26, 2019
LEAM vs. BEAM vs. CLV Conditioning Regimen for Autologous Stem Cell Transplantation in Malignant Lymphomas. Retrospective Comparison of Toxicity and Efficacy on 222 Patients in the First 100 Days After Transplant, On Behalf of the Romanian Society for Bone Marrow TransplantationAndrei Colita, Anca Colita, Horia Bumbea, et al.
Cell Death Discovery|August 13, 2025
Comprehensive view on chemotherapy-free management of acute myeloid leukemia by using venetoclax in combination with targeted and/or immune therapiesDavid Kegyes, Andrei Tat, Alin Stefan Vizitiu, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|December 24, 2015
Exosome-Carried microRNA-375 Inhibits Cell Progression and Dissemination via Bcl-2 Blocking in Colon CancerFlorin Zaharie, Mihai Stefan Muresan, Bobe Petrushev, et al.
Biomarker Research|August 15, 2025
Targeting degradation of IKZF1 and IKZF3 through modulation of the E3 ligase substrates in the context of cellular therapies for multiple myelomaDavid Kegyes, Anamaria Bancos, Adrian Bogdan Tigu, et al.
Journal of Clinical Medicine|October 29, 2020
B Cells versus T Cells in the Tumor Microenvironment of Malignant Lymphomas. Are the Lymphocytes Playing the Roles of Muhammad Ali versus George Foreman in Zaire 1974?Minodora Desmirean, Sebastian Rauch, Ancuta Jurj, et al.
Leukemia & Lymphoma|February 11, 2022
Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy<sup></sup>Toshihiro Miyamoto, David Sanford, Ciprian Tomuleasa, et al.
Critical Reviews in Clinical Laboratory Sciences|May 27, 2018
Minimal residual disease in chronic lymphocytic leukemia: A consensus paper that presents the clinical impact of the presently available laboratory approachesCiprian Tomuleasa, Cristina Selicean, Sonia Cismas, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|August 7, 2021
SERS-based DNA methylation profiling allows the differential diagnosis of malignant lymphadenopathyAndrei Stefancu, Vlad Moisoiu, Minodora Desmirean, et al.
Frontiers in Immunology|August 27, 2025
Challenges in the preclinical design and assessment of CAR-T cellsRadu Tomai, Javier De Las Rivas, Bogdan Fetica, et al.
Pageof 20